Three States Renew Legal Battle to Restrict Abortion Pill Access

Missouri, Kansas, and Idaho challenge FDA policies on mifepristone, aiming to reinstate stricter regulations despite Supreme Court rulings.

The states' lawsuit seeks to require in-person dispensing of mifepristone and limit its use to seven weeks of pregnancy.
The case is filed in a Texas federal court, following a Supreme Court decision that maintained eased access to the drug.
The states argue the FDA's relaxed rules undermine their abortion laws and disrupt enforcement efforts.
Medication abortions account for nearly two-thirds of all abortions in the U.S., with expanded access since Roe v. Wade was overturned.
Medical organizations affirm mifepristone's safety, disputing claims of increased emergency complications.